Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials

NCT00362505 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bukwang Pharmaceutical